Despite having yet to save a mouse, last week a company created headlines when it said that it would cure all cancers -- in a year. Let's clarify what promise actually exists in the field, and what hurdles still need to be overcome.
Complementary medicine ranges from authentic stress-relieving massage to well-meaning (but expensive) placebo, to outright spurious healing claims. Researchers decided to study its impact on patients with curable cancers.
A new study in the British Medical Journal suggests that the majority of new cancer drugs approved by the European Medicines Agency lacked evidence that they improved survival or the quality of life of patients.
The U.S. Prevention Services Task Force released its 2017 draft recommendations for prostate cancer screening. Here we extensively address the new guidelines, clarify the role of the PSA test, and delve deeper into the topic with Dr. David Samadi, Chairman of Urology and Chief of Robotic Surgery at New York's Lenox Hill Hospital.
The concluding piece in this Brain Tumor series spotlights the expertise of Dr. Gregory Riggins. A professor of Neurosurgery and Oncology, and Director of the Brain Cancer Biology and Therapy Research Laboratory at Johns Hopkins, he will help us distinguish myth from reality.
Aside from occasional high-profile cases and Hollywood movies, brain tumors rarely take center stage. But when they do, it tends to be an ominous story. The CDC recently reported brain cancer surpassed leukemia as the most common cancer-causing death in children aged 1-19, but no age is safe. Here's the first of a two-part series elucidating fact from fiction.
A study published in this month s Journal of Urology outlines a better than 90% effectiveness of dogs at detecting prostate cancer by sniffing a patient s urine. The researchers, based in Italy, trained two 3-year-old female German Shepherds for 5 months using operant
In 2015, an estimated 21,000 American women will be diagnosed with ovarian cancer and over 14,000 women will die from the disease. Ovarian cancer ranks fifth in cancer deaths
No medical organization recommends the prostate-specific antigen test for older men, and yet many primary care doctors continue to administer it even to those over age 75. Why?